Larvol Delta - Carrick-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-Samuraciclib-in-Combination-with-Elacestrant-in-Patients-with-Advanced-Breast-Cancer

samuraciclib (CT7001) - Carrick Therap

https://www.globenewswire.com/news-release/2023/10/18/2762408/0/en/Carrick-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-Samuraciclib-in-Combination-with-Elacestrant-in-Patients-with-Advanced-Breast-Cancer.html

Oct 18, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next